Publications by authors named "Sarah F Christensen"

Claim this Profile
S
Statins enhance the efficacy of pegylated interferon-alfa2 in Philadelphia-negative chronic myeloproliferative neoplasms.
Isabella Diana Davidsen, Morten Kranker Larsen, Lea Löffler, Vibe Skov, Lasse Kjær, Sarah Friis Christensen

Blood Adv· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
J
JAK2V617F drives gut microbiota differences in patients with myeloproliferative neoplasms.
Christina Schjellerup Eickhardt-Dalbøge, Henrik V Nielsen, Kurt Fuursted, Christen Rune Stensvold, Lee O' Brien Andersen, Sarah Friis Christensen, Jens Jørgen Elmer Christensen

Eur J Haematol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Labor market affiliation of patients with myeloproliferative neoplasms: a population-based matched cohort study.
Lise Skovgaard Svingel, Sarah Friis Christensen, Anders Kjærsgaard, Anna Stenling, Björn Paulsson

Acta Oncol· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pronounced gut microbiota signatures in patients with positive essential thrombocythemia.
Christina Schjellerup Eickhardt-Dalbøge, Anna Cäcilia Ingham, Henrik V Nielsen, Kurt Fuursted, Christen Rune Stensvold, Sarah Friis Christensen, Jens Jørgen Elmer Christensen

Microbiol Spectr· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The gut microbiota in patients with polycythemia vera is distinct from that of healthy controls and varies by treatment.
Christina Schjellerup Eickhardt-Dalbøge, Anna Cäcilia Ingham, Lee O'Brien Andersen, Henrik V Nielsen, Kurt Fuursted, Sarah Friis Christensen, Jens Jørgen Elmer Christensen

Blood Adv· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Healthcare resource utilization in patients with myeloproliferative neoplasms: A Danish nationwide matched cohort study.
Sarah Friis Christensen, Lise Skovgaard Svingel, Anders Kjaersgaard, Anna Stenling, Bianka Darvalics

Eur J Haematol· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Elevated blood cell counts and vascular disease with the myeloproliferative neoplasms as model diseases].
Hans Carl Hasselbalch, Trine Alma Knudsen, Anders Lindholm Sørensen, Sarah Friis Christensen, Morten Kranker Larsen

Ugeskr Laeger· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tobacco use in the Myeloproliferative neoplasms: symptom burden, patient opinions, and care.
Sarah F Christensen, Robyn M Scherber, Gina L Mazza, Amylou C Dueck, Nana Brochmann

BMC Cancer· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Body Mass Index and Total Symptom Burden in Myeloproliferative Neoplasms Discovery of a U-shaped Association.
Sarah Friis Christensen, Robyn Marie Scherber, Nana Brochmann, Martin Goros, Jonathan Gelfond

Cancers (Basel)· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Marked differences in GPs' diagnosis of pneumonia between Denmark and Spain: a cross-sectional study.
Sarah Friis Christensen, Lars Christian Jørgensen, Gloria Cordoba, Carl Llor, Volkert Siersma

Prim Care Respir J· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis